Celldex (CLDX) Posts Smaller Q4 Loss

Celldex (NASDAQ: CLDX) reported Q4 EPS of ($0.03), $0.22 better than the analyst estimate of ($0.25). Revenue for the quarter came in at $3.5 million versus the consensus estimate of $1.35 million.

For earnings history and earnings-related data on Celldex (CLDX) click here.

You May Also Be Interested In

• TriNet Group (TNET) Misses Q1 EPS by 30c, Updates Guidance
• Richmond Mutual Bancorporation, Inc. (RMBI) Reports Q1 EPS of $0.23
• Codorus Valley Bancorp (CVLY) Misses Q1 EPS by 2c